Clinical trial shows oral semaglutide vastly reduces heart attacks, strokes in people with type 2 diabetes
Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention ...
News-Medical.Net on MSN4d
New trial shows oral semaglutide reduces cardiovascular events in diabetes patients
Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention for their effectiveness against weight gain, high blood sugar, and even ...